SEC Form 4 · accession 0001209191-15-056296
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Daly
Officer — EVP, Chief Commercial Officer
Period of report
Jun 23, 2015
Accepted (ET)
Jun 25, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 23, 2015 | M | 2,778 | $18.32 | A | 6,299 | D | |
| Common Stock | Jun 23, 2015 | M | 7,331 | $16.62 | A | 13,630 | D | |
| Common Stock | Jun 23, 2015 | M | 601 | $16.62 | A | 14,231 | D | |
| Common StockF1,F2,F3 | Jun 23, 2015 | S | 10,710 | $108.28 | D | 3,521 | D | |
| Common Stock | Jun 23, 2015 | M | 981 | $64.55 | A | 4,502 | D | |
| Common StockF2,F3,F4 | Jun 23, 2015 | S | 981 | $107.84 | D | 3,521 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F5 | $18.32 | Jun 23, 2015 | M | 2,778 | D | — | Feb 8, 2020 | Common Stock | 2,778 | 16,765 | D |
| Non-Qualified Stock Option (right to buy)F6 | $16.62 | Jun 23, 2015 | M | 7,331 | D | — | Oct 21, 2019 | Common Stock | 7,331 | 30,928 | D |
| Non-Qualified Stock Option (right to buy)F6 | $16.62 | Jun 23, 2015 | M | 601 | D | — | Oct 21, 2019 | Common Stock | 601 | 2,407 | D |
| Non-Qualified Stock Option (right to buy)F7 | $64.55 | Jun 23, 2015 | M | 981 | D | — | Jan 20, 2021 | Common Stock | 981 | 17,662 | D |
Explanation of responses
- F1Represents weighted average sale price. Actual sale prices ranged from $107.11 - $109.51.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F3Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- F4Represents weighted average sale price. Actual sale prices ranged from $107.81 - $107.84.
- F5Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F6Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- F7Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.